Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2023

Every FDA drug recall initiated in 2023, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,122 recalls, newest first.

Class III · Low risk

Avicel PH-200 NF

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Terminated Impurity / degradation DuPont Nutrition USA, Inc D-0351-2023
Class III · Low risk

Avicel PH- 102 NF

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Terminated Impurity / degradation DuPont Nutrition USA, Inc D-0350-2023
Class III · Low risk

Avicel PH- 101 NF

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Terminated Impurity / degradation DuPont Nutrition USA, Inc D-0349-2023
Class II · Moderate risk

Delsam Pharma's ARTIFICIAL TEARS

CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.

Ongoing cGMP deviation Global Pharma Healthcare Private Limited D-0922-2023
Class II · Moderate risk

Artificial Tears

CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.

Ongoing cGMP deviation Global Pharma Healthcare Private Limited NDC 79503-0101-15 D-0920-2023
Class I · High risk

Artificial Tears

Non-Sterility: FDA analysis found unopened products to have bacterial contamination.

Ongoing Sterility / contamination Global Pharma Healthcare Private Limited NDC 79503-0101-15 D-0919-2023

Recalls by year